Cargando…

Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials

In 2014 and 2021, two nucleic-acid vaccine candidates named MAV E2 and VGX-3100 completed phase III clinical trials in Mexico and U.S., respectively, for patients with human papillomavirus (HPV)-related, high-grade squamous intraepithelial lesions (HSIL). These well-tolerated but still unlicensed va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jianming, Li, Mingzhu, Zhao, Chao, Shen, Danhua, Liu, Lei, Zhang, Xiujun, Wei, Lihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874761/ https://www.ncbi.nlm.nih.gov/pubmed/35215833 http://dx.doi.org/10.3390/v14020239

Ejemplares similares

Therapeutic Vaccines for HPV-Associated Malignancies
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Age-Stratified Analysis of Vaginal Microbiota Dysbiosis and the Relationship with HPV Viral Load in HPV-Positive Women
por: Li, Mingzhu, et al.
Publicado: (2022)

DNA vaccination against oncoantigens: A promise
por: Iezzi, Manuela, et al.
Publicado: (2012)

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China
por: Wei, Lihui, et al.
Publicado: (2021)

DnaJ, a promising vaccine candidate against Ureaplasma urealyticum infection
por: Guo, Fangyi, et al.
Publicado: (2022)

Echinomycin as a promising therapeutic agent against KSHV-related malignancies
por: Chen, Jungang, et al.
Publicado: (2023)

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
por: Peng, Shiwen, et al.
Publicado: (2014)

Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects
por: Chuang, Chi-Mu, et al.
Publicado: (2009)

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
por: Chuang, Chi-Mu, et al.
Publicado: (2010)

Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
por: Tahamtan, Alireza, et al.
Publicado: (2014)

Perspectives for therapeutic HPV vaccine development
por: Yang, Andrew, et al.
Publicado: (2016)

Therapeutic Vaccination for HPV-Mediated Cancers
por: Yan, Flora, et al.
Publicado: (2023)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

Fusion of CTLA-4 with HPV16 E7 and E6 Enhanced the Potency of Therapeutic HPV DNA Vaccine
por: Gan, Lili, et al.
Publicado: (2014)

The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan
por: Yagi, Asami, et al.
Publicado: (2022)

Underdiagnosis of cervical intraepithelial neoplasia by colposcopy and its association with thin high‑grade squamous intraepithelial lesions
por: Li, Mingzhu, et al.
Publicado: (2023)

Therapeutic Vaccination for HPV Induced Cervical Cancers
por: Brinkman, Joeli A., et al.
Publicado: (2007)

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Novel Antigenic Targets of HPV Therapeutic Vaccines
por: Boilesen, Ditte Rahbæk, et al.
Publicado: (2021)

The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age
por: Zhao, Chao, et al.
Publicado: (2022)

The Acceptability of HPV Vaccines and Perceptions of Vaccination against HPV among Physicians and Nurses in Hong Kong
por: Cheung, Teris, et al.
Publicado: (2019)

Association and Effectiveness of PAX1 Methylation and HPV Viral Load for the Detection of Cervical High-Grade Squamous Intraepithelial Lesion
por: Li, Mingzhu, et al.
Publicado: (2022)

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011)

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
por: Kim, Tae Jin, et al.
Publicado: (2014)

Immunizing against Anogenital Cancer: HPV Vaccines
por: Pogoda, Cloe S., et al.
Publicado: (2016)

Therapeutic vaccines for high-risk HPV-associated diseases
por: Chabeda, Aleyo, et al.
Publicado: (2017)

Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016)

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

National HPV Vaccination Program in Poland—Public Awareness, Sources of Knowledge, and Willingness to Vaccinate Children against HPV
por: Jankowski, Mateusz, et al.
Publicado: (2023)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

RUNX2 as a promising therapeutic target for malignant tumors
por: Zhao, Weizhu, et al.
Publicado: (2021)

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
por: Kodama, Yuta, et al.
Publicado: (2021)

Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
por: Donninger, Howard, et al.
Publicado: (2021)

Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021)

Vaccination against HPV: boosting coverage and tackling misinformation
por: Bigaard, Janne, et al.
Publicado: (2020)

Vaccination against HPV: Easier said than done?
por: Stoeklé, Henri-Corto, et al.
Publicado: (2023)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

Prophylactic and therapeutic DNA vaccines against Chagas disease
por: Arce-Fonseca, Minerva, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ltond1hlck84vnijh46kuibtrk